Original article| Volume 17, ISSUE 3, P575-584, March 2021

Effects of body composition profiles on oncological outcomes and postoperative intraabdominal infection following colorectal cancer surgery

Published:October 26, 2020DOI:


      • Myopenia and adiposity show prognostic effects on DFS in patients with colorectal cancer
      • subcutaneous adipose tissue reflects an energetic storage favorable to face colorectal cancer
      • Muscle mass loss may represent a modifiable risk factor in colorectal cancer
      • Interpretation of CRP level must take into account adiposity to avoid unnecessary interventions



      Anthropometric data as prognostic factors of colorectal cancer are promising but contradictory. The aim of this study was to assess the preoperative body composition profiles as predictive factors for postoperative, oncologic, and inflammation outcomes.


      We sought to assess the impact of body composition profiles on short- and long-term outcomes and on postoperative inflammatory response in a clinical setting for patients following curative intent surgery for colorectal cancer.


      University hopsital


      We analyzed 122 patients from a prospective cohort (IMACORS) with colorectal cancer undergoing curative-intent surgery from 2011 to 2014. Musculature, total, visceral, and subcutaneous adiposity were measured from a preoperative CT scan and outcomes were compared between profiles.


      Preoperative myopenia was an independent predictive factor of recurrence (HR = 3.3 95% CI = 1.6–6.9; P = .002) while subcutaneous adiposity was a protective factor (HR = .4 95% CI = .2–.9; P = .03). No anthropometric measurement was predictive of overall survival and postoperative intra abdominal infection was not determined by body composition profiles. Preoperative and D4 CRP levels were significantly higher in patients with subcutaneous adiposity.


      Myopenia and subcutaneous adiposity seemed to have independent and opposite prognostic effects on recurrence. Muscle mass loss may represent a modifiable risk factor while the amount of subcutaneous adipose tissue reflects an energetic storage favorable to face this pathologic process.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bray F.
        • Ferlay J.
        • Soerjomataram I.
        • Siegel R.L.
        • Torre L.A.
        • Jemal A.
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2018; 68: 394-424
        • Le Voyer T.E.
        • Sigurdson E.R.
        • Hanlon A.L.
        • et al.
        Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.
        J Clin Oncol. 2003; 21: 2912-2919
        • Cakir H.
        • Heus C.
        • van der Ploeg T.J.
        • Houdijk A.P.J.
        Visceral obesity determined by CT scan and outcomes after colorectal surgery; a systematic review and meta-analysis.
        Int J Colorectal Dis. 2015; 30: 875-882
        • Malietzis G.
        • Currie A.C.
        • Athanasiou T.
        • et al.
        Influence of body composition profile on outcomes following colorectal cancer surgery.
        Br J Surg. 2016; 103: 572-580
        • Malietzis G.
        • Aziz O.
        • Bagnall N.M.
        • Johns N.
        • Fearon K.C.
        • Jenkins J.T.
        The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: A systematic review.
        Eur J Surg Oncol. 2015; 41: 186-196
        • Maurovich-Horvat P.
        • Massaro J.
        • Fox C.S.
        • Moselewski F.
        • O’Donnell C.J.
        • Hoffmann U.
        Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography.
        Int J Obes 2005. 2007; 31: 500-506
        • Yoshizumi T.
        • Nakamura T.
        • Yamane M.
        • et al.
        Abdominal fat: standardized technique for measurement at CT.
        Radiology. 1999; 211: 283-286
        • Gradmark A.M.I.
        • Rydh A.
        • Renström F.
        • et al.
        Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry.
        Br J Nutr. 2010; 104: 582-588
        • Prado C.M.M.
        • Lieffers J.R.
        • McCargar L.J.
        • et al.
        Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
        Lancet Oncol. 2008; 9: 629-635
        • Black D.
        • Mackay C.
        • Ramsay G.
        • Hamoodi Z.
        • et al.
        Prognostic value of computed tomography: measured parameters of body composition in primary operable gastrointestinal cancers.
        Ann Surg Oncol. 2017; 24: 2241-2251
        • Feliciano E.M.C.
        • Kroenke C.H.
        • Meyerhardt J.A.
        • et al.
        Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS Study.
        JAMA Oncol. 2017; 3e172319
        • Ouchi A.
        • Asano M.
        • Aono K.
        • Watanabe T.
        • Oya S.
        Laparoscopic colorectal resection in patients with sarcopenia: a retrospective case-control study.
        J Laparoendosc Adv Surg Tech A. 2016; 26: 366-370
        • Mahamid A.
        • Ashkenazi I.
        • Shapira-Rootman M.
        • et al.
        Impact of increased visceral fat measured by CT on colon adenocarcinoma stage.
        J Gastrointest Cancer. 2017; 48: 347-352
        • Ebadi M.
        • Martin L.
        • Ghosh S.
        • et al.
        Subcutaneous adiposity is an independent predictor of mortality in cancer patients.
        Br J Cancer. 2017; 117: 148-155
        • Su H.
        • Ruan J.
        • Chen T.
        • Lin E.
        • Shi L.
        CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis.
        Cancer Imaging. 2019; 19: 82
        • Caan B.J.
        • Meyerhardt J.A.
        • Kroenke C.H.
        • et al.
        Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study).
        Cancer Epidemiol Biomark Prev. 2017; 26: 1008-1015
        • Amundson D.E.
        • Djurkovic S.
        • Matwiyoff G.N.
        The obesity paradox.
        Crit Care Clin. 2010; 26: 583-596
        • Nattenmüller J.
        • Böhm J.
        • Bagdassarjan A.
        • et al.
        CT-quantified adipose tissue distribution: risk or protective factor for complications after rectal cancer surgery?.
        Obes Facts. 2019; 12: 259-271
        • Richards C.H.
        • Leitch E.F.
        • Horgan P.G.
        • Anderson J.H.
        • McKee R.F.
        • McMillan D.C.
        The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer.
        Br J Cancer. 2010; 103: 1356-1361
        • Richards C.H.
        • Roxburgh C.S.D.
        • MacMillan M.T.
        • et al.
        The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer.
        PloS One. 2012; 7e41883
        • Sinicrope F.A.
        • Foster N.R.
        • Sargent D.J.
        • O’Connell M.J.
        • Rankin C.
        Obesity is an independent prognostic variable in colon cancer survivors.
        Clin Cancer Res. 2010; 16: 1884-1893
        • Okugawa Y.
        • Toiyama Y.
        • Yamamoto A.
        • et al.
        Close relationship between immunological/inflammatory markers and myopenia and myosteatosis in patients with colorectal cancer: a propensity score matching analysis.
        JPEN J Parenter Enteral Nutr. 2019; 43: 508-515
        • Dev R.
        • Bruera E.
        • Dalal S.
        Insulin resistance and body composition in cancer patients.
        Ann Oncol. 2018; 29: ii18-ii26
        • Ebadi M.
        • Baracos V.E.
        • Bathe O.F.
        • Robinson L.E.
        • Mazurak V.C.
        Loss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content.
        Clin Nutr. 2016; 35: 1347-1353
        • Riondino S.
        • Roselli M.
        • Palmirotta R.
        • Della-Morte D.
        • Ferroni P.
        • Guadagni F.
        Obesity and colorectal cancer: role of adipokines in tumor initiation and progression.
        World J Gastroenterol. 2014; 20: 5177-5190
        • Quail D.F.
        • Dannenberg A.J.
        The obese adipose tissue microenvironment in cancer development and progression.
        Nat Rev Endocrinol. 2019; 15: 139-154
        • Facy O.
        • Paquette B.
        • Orry D.
        • et al.
        Diagnostic accuracy of inflammatory markers as early predictors of infection after elective colorectal surgery: results from the IMACORS Study.
        Ann Surg. 2016; 263: 961-966
        • McMillan D.C.
        • Canna K.
        • McArdle C.S.
        Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
        Br J Surg. 2003; 90: 215-219
        • Crozier J.E.M.
        • McKee R.F.
        • McArdle C.S.
        • et al.
        Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer.
        Br J Surg. 2007; 94: 1028-1032
        • Almasaudi A.S.
        • McSorley S.T.
        • Dolan R.D.
        • Edwards C.A.
        • McMillan D.C.
        The relation between Malnutrition Universal Screening Tool (MUST), computed tomography-derived body composition, systemic inflammation, and clinical outcomes in patients undergoing surgery for colorectal cancer.
        Am J Clin Nutr. 2019; 110: 1327-1334
        • Dolan R.D.
        • Almasaudi A.S.
        • Dieu L.B.
        • Horgan P.G.
        • McSorley S.T.
        • McMillan D.C.
        The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
        J Cachexia Sarcopenia Muscle. 2019; 10: 111-122
      1. Amin MB, American Joint Committee on Cancer, American Cancer Society, editors. AJCC cancer staging manual. Eight edition/editor-in-chief, Mahul B. Amin, MD, FCAP; editors, Stephen B. Edge, MD, FACS [and 16 others]; Donna M. Gress, RHIT, CTR-Technical editor; Laura R. Meyer, CAPM-Managing editor. Chicago IL: American Joint Committee on Cancer, Springer; 2017.

        • Horan T.C.
        • Andrus M.
        • Dudeck M.A.
        CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.
        Am J Infect Control. 2008; 36: 309-332
      2. Lecomte T, André T, Bibeau F et al. « Cancer du côlon non métastatique » Thésaurus National de Cancérologie Digestive, Janvier 2019, n.d. [ et]

        • Mourtzakis M.
        • Prado C.M.M.
        • Lieffers J.R.
        • Reiman T.
        • McCargar L.J.
        • Baracos V.E.
        A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.
        Appl Physiol Nutr Metab. 2008; 33: 997-1006
        • Mitsiopoulos N.
        • Baumgartner R.N.
        • Heymsfield S.B.
        • Lyons W.
        • Gallagher D.
        • Ross R.
        Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.
        J Appl Physiol (1985). 1998; 85: 115-122
        • Gomez-Perez S.L.
        • Haus J.M.
        • Sheean P.
        • et al.
        Measuring Abdominal Circumference and Skeletal Muscle From a Single Cross-Sectional Computed Tomography Image: A Step-by-Step Guide for Clinicians Using National Institutes of Health ImageJ.
        JPEN J Parenter Enteral Nutr. 2016; 40: 308-318
        • Baumgartner R.N.
        • Koehler K.M.
        • Gallagher D.
        • et al.
        Epidemiology of sarcopenia among the elderly in New Mexico.
        Am J Epidemiol. 1998; 147: 755-763
        • Lieffers J.R.
        • Bathe O.F.
        • Fassbender K.
        • Winget M.
        • Baracos V.E.
        Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery.
        Br J Cancer. 2012; 107: 931-936
        • Reisinger K.W.
        • van Vugt J.L.A.
        • Tegels J.J.W.
        • et al.
        Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery.
        Ann Surg. 2015; 261: 345-352
        • Mandrekar J.N.
        • Mandrekar S.J.
        • Cha S.S.
        Cutpoint determination methods in survival analysis using SAS®.
        (261-28 n.d.; SUGI 28)
        • Park H.S.
        • Kim H.S.
        • Beom S.H.
        • et al.
        Marked loss of muscle, visceral fat, or subcutaneous fat after gastrectomy predicts poor survival in advanced gastric cancer: single-center study from the CLASSIC Trial.
        Ann Surg Oncol. 2018; 25: 3222-3230
        • Charette N.
        • Vandeputte C.
        • Ameye L.
        • et al.
        Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
        BMC Cancer. 2019; 19: 134
        • Hopkins J.J.
        • Reif R.L.
        • Bigam D.L.
        • Baracos V.E.
        • Eurich D.T.
        • Sawyer M.B.
        The impact of muscle and adipose tissue on long-term survival in patients with Stage I to III colorectal cancer.
        Dis Colon Rectum. 2019; 62: 549-560
        • Doyle S.L.
        • Bennett A.M.
        • Donohoe C.L.
        • et al.
        Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research.
        Nutr Res. 2013; 33: 171-179
        • Arends J.
        • Baracos V.
        • Bertz H.
        • et al.
        ESPEN expert group recommendations for action against cancer-related malnutrition.
        Clin Nutr. 2017; 36: 1187-1196
        • Kyrgiou M.
        • Kalliala I.
        • Markozannes G.
        • et al.
        Adiposity and cancer at major anatomical sites: umbrella review of the literature.
        BMJ. 2017; : j477
        • Renehan A.G.
        • Tyson M.
        • Egger M.
        • Heller R.F.
        • Zwahlen M.
        Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
        Lancet. 2008; 371: 569-578
        • Ortega-Deballon P.
        • Duvillard L.
        • Scherrer M.-L.
        • et al.
        Preoperative adipocytokines as a predictor of surgical infection after colorectal surgery: a prospective survey.
        Int J Colorectal Dis. 2014; 29: 23-29
        • Bardou M.
        • Barkun A.N.
        • Martel M.
        Obesity and colorectal cancer.
        Gut. 2013; 62: 933-947
        • Hughes V.
        The big fat truth.
        Nature. 2013; 497: 428-430
      3. Kaltenmeier C, Shen C, Medich DS, Geller DA, Bartlett DL, Tsung A, Tohme S. Time to Surgery and Colon Cancer Survival in the United States. Ann Surg. 2019 Dec 10. Epub ahead of print.

        • Devin J.L.
        • Sax A.T.
        • Hughes G.I.
        • et al.
        The influence of high-intensity compared with moderate-intensity exercise training on cardiorespiratory fitness and body composition in colorectal cancer survivors: a randomised controlled trial.
        J Cancer Surviv. 2016; 10: 467-479
        • Katakami N.
        • Uchino J.
        • Yokoyama T.
        • et al.
        Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
        Cancer. 2018; 124: 606-616
        • Jain R.
        • Handorf E.
        • Khare V.
        • Blau M.
        • Chertock Y.
        • Hall M.J.
        Impact of baseline nutrition and exercise status on toxicity and outcomes in phase I and II Oncology Clinical Trial Participants.
        Oncologist. 2019;
        • Hilmi M.
        • Jouinot A.
        • Burns R.
        • et al.
        Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?.
        Pharmacol Ther. 2019; 196: 135-159